Achema middle east

Press Releases

Provepharm Life Solutions forms alliance with new strategic partners, ArchiMed and Téthys Invest

Provepharm Life Solutions announces that ArchiMed and Téthys Invest have joined the company’s shareholder base as minority investors. Both are renowned investors with strong expertise in the healthcare sector. Beyond financial considerations, it was the specific...

Porton Pharma Solutions and Codexis Launch Global Partnership

Codexis, Inc and Porton Pharma Solutions, Ltd announce a strategic collaboration to deploy Codexis’ world-leading biocatalyst technology within Porton’s global custom intermediate and active pharmaceutical ingredients (API) development and manufacturing business. The partnership will accelerate the...

Hear FromRegulatory and Pharmaceutical Industry Leaders this June

The 6th annual conference will gather the growing freeze drying community, filled with industry thought leaders and principle scientists involved in: manufacturing, material sciences, bio-therapeutics and pharmaceutical engineering. If you haven't checked out the agenda yet,...

SMi’s Injectable Drug Delivery Releases an Exclusive Interview by Roche

SMi are delighted to have interviewed our speaker Maxime Gaillot, Senior Device Engineer, Roche, for Injectable Drug Delivery! Maxime Gaillot works for Roche since 2011. He has 15 years’ experience in the medical device and polymer...

TraceLink Unveils EU FMD Express, a Purpose-Built Compliance Solution for Smaller Pharmaceutical Companies

TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, announced EU FMD Express – a cost-effective, simplified solution designed specifically to address the...

The Best Gateway into the Dynamic Korean Pharma & Bio-Pharma Market!

Bio industry which is linked closely with pharmaceutical industry comes into the spotlight as new growth power in globally. KOREA PHARM recreate under the name of “Korea Int’l Pharmaceutical & bio-Pharma Exhibition”.  KOREA PHARM & BIO...

Lokelma approved in the EU for the treatment of adults with hyperkalaemia

AstraZeneca announced that the EC has granted marketing authorisation for Lokelma (formerly ZS-9, sodium zirconium cyclosilicate) for the treatment of adults with hyperkalaemia. Hyperkalaemia is a serious condition characterised by elevated potassium levels in the blood...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »